CompletedACTRN12625000876493
Official study titleA Phase 1b, Randomized, Double-Blind, Placebo-Controlled Evaluation of selected Pharmacodynamic Biomarkers in Cerebrospinal Fluid (CSF) Following 24-hour Intravenous Infusion of EVX-301 in Adults with Depression Receiving Stable Antidepressant Treatment
This study has finished and is no longer accepting participants.
In AdelaideDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Evecxia Therapeutics, Inc.
CompletedEUCTR 2005-003180-23
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicAnxietyHistorical research record
- Countries
- Czechia
- Sponsor
- sanofi-aventis recherche & développement
CompletedEUCTR 2007-007555-14
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaBipolarity, DepressionHistorical research record
- Countries
- Bulgaria, Hungary
- Sponsor
- Cephalon, Inc.
CompletedEUCTR 2004-001500-13
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In IrelandAnxietyHistorical research record
- Countries
- United Kingdom, Ireland, Italy, + 2 others
- Sponsor
- Pfizer Ltd.
CompletedACTRN12618002045291
Official study titleExploring early pathways to mental illness and related harms: An implementation feasibility and acceptability study of the Good Behaviour Game in Australian Primary Schools
This study has finished and is no longer accepting participants.
In AustraliaMental healthInterventional studyAges 6–12
- Countries
- Australia
- Sponsor
- Helen Christensen
CompletedNCT00878462
About this title
An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)
Read the official source — NCT00878462Official study titleA Randomized, Crossover Study Evaluating the Acceptability of Unflavored Asenapine and Raspberry Flavored Asenapine in Stable Subjects With A Psychotic Disorder
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT07656220
This study has finished and is no longer accepting participants.
In NorwichAnxietyBehavioural studyAges 18+
- Countries
- United Kingdom
- Sponsor
- University of East Anglia
CompletedNCT02130596
About this title
An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic Illness
Read the official source — NCT02130596Official study titleA Pilot Study of an Acceptance-Based Behavioral Intervention Versus Nutritional Counseling for Weight Loss in Psychotic Illness
This study has finished and is no longer accepting participants.
In TorontoSchizophreniaBehavioural studyAges 18–70
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT02058121
About this title
An ACT Group Intervention for ED-patients
Read the official source — NCT02058121Official study titleRandomised Controlled Trial With Acceptance and Commitment Therapy (ACT) for Patients With Eating Disorders - a Manualised Group Therapy to Enhance Body Acceptance
This study has finished and is no longer accepting participants.
In ÖrebroEating disordersBehavioural studyAges 16–50
- Countries
- Sweden
- Sponsor
- Örebro County Council
CompletedNCT03055338
What is this study about?This study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
CompletedNCT03222570
This study has finished and is no longer accepting participants.
In MinneapolisDepressionMedication studyAges 12–18
- Countries
- United States
- Sponsor
- University of Minnesota
CompletedNCT03838198
Official study titleDeveloping an Adaptive Intervention for Suicidal Adolescents Following Inpatient Hospitalization: A Pilot SMART
This study has finished and is no longer accepting participants.
In Ann ArborSuicidalityBehavioural studyAges 13–17
- Countries
- United States
- Sponsor
- University of Michigan
